JERUSALEM (Reuters) -The coronavirus variant discovered in South Africa may evade the protection provided by Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found…..
The South African variant, B.1.351, was found to make up about 1% of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel’s largest healthcare provider, Clalit.
But among patients who had received two doses of the vaccine, the variant’s prevalence rate was eight times higher than those unvaccinated – 5.4% versus 0.7%.South African variant may evade protection from Pfizer vaccine, Israeli study says | Reuters
Just like with the flu vaccine, it does not protect against mutations. Coronavirus mutates rapidly, and there are already 4,000 mutations of COVID-19. Trying to claim that a vaccine will protect against all mutations is like trying to use a child’s sand bucket and sand shovel to stop the tide from coming in. The flu vaccine does not stop the flu virus, which mutates hundreds of times per year.